Therapeutic and Pharmaceutical Applications of Pegylated Nano-Carriers

dc.contributor.author Shakeri, R.
dc.contributor.author Mirjalili, S.Z.
dc.contributor.author Karakus, C.O.
dc.contributor.author Safavi, M.
dc.date.accessioned 2025-06-26T20:20:30Z
dc.date.available 2025-06-26T20:20:30Z
dc.date.issued 2025
dc.description.abstract The coating of the exterior of nanocarriers with polyethylene glycol (PEG; known as “PEGylation”), has emerged as one of the most widely adopted approaches to impart stealth properties to pharmaceutical nanocarrier systems. The PEGylation tactic offers a stealth barrier towards the adsorption of circulatory proteins owing to its hydrophilicity, elasticity, neutralization, and hydration properties. PEGylation dramatically provides sustained drug release benefits, reduces immune sensitivity, as well as improves the systemic circulation period, Overall, PEGylation effectively improves the therapeutic efficacy of the loaded therapeutic moiety in treating target cells and tissues. This chapter offers discussion on drug delivery nanosystems that are developed based on the principle of PEGylation strategy. Furthermore, a detailed account of the pharmaceutical and biomedical applications of PEGylated nanocarriers has also been presented in detail. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2024. en_US
dc.identifier.doi 10.1007/978-981-97-7316-9_18
dc.identifier.isbn 9789819773169
dc.identifier.isbn 9789819773152
dc.identifier.scopus 2-s2.0-105007409800
dc.identifier.uri https://doi.org/10.1007/978-981-97-7316-9_18
dc.identifier.uri https://hdl.handle.net/11147/15686
dc.language.iso en en_US
dc.publisher Springer Nature en_US
dc.relation.ispartof PEGylated Nanocarriers in Medicine and Pharmacy en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Immunosensitivity en_US
dc.subject Pharmaceutical Applications en_US
dc.subject Stealth Properties en_US
dc.subject Therapeutic Benefits en_US
dc.title Therapeutic and Pharmaceutical Applications of Pegylated Nano-Carriers en_US
dc.type Book Part en_US
dspace.entity.type Publication
gdc.author.scopusid 55932020200
gdc.author.scopusid 57218911376
gdc.author.scopusid 58882532000
gdc.author.scopusid 25227167300
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access metadata only access
gdc.coar.type text::book::book part
gdc.collaboration.industrial false
gdc.description.department İzmir Institute of Technology en_US
gdc.description.departmenttemp [Shakeri R.] Faculty of Science, Department of Biological Science, University of Kurdistan, Sanandaj, Iran; [Mirjalili S.Z.] Faculty of Pharmacy, Drug and Food Control Department, Tehran University of Medical Sciences, Tehran, Iran; [Karakus C.O.] Department of Bioengineering, Izmir Institute of Technology, Izmir, Turkey; [Safavi M.] Department of Biotechnology, Iranian Research Organization for Science and Technology, Tehran, Iran en_US
gdc.description.endpage 602 en_US
gdc.description.publicationcategory Kitap Bölümü - Uluslararası en_US
gdc.description.startpage 555 en_US
gdc.identifier.openalex W4408069809
gdc.index.type Scopus
gdc.oaire.diamondjournal false
gdc.oaire.impulse 0.0
gdc.oaire.influence 2.635068E-9
gdc.oaire.isgreen false
gdc.oaire.popularity 2.1091297E-10
gdc.oaire.publicfunded false
gdc.openalex.collaboration International
gdc.openalex.fwci 0.0
gdc.openalex.normalizedpercentile 0.11
gdc.openalex.toppercent TOP 10%
gdc.opencitations.count 0
gdc.plumx.mendeley 5
gdc.plumx.scopuscites 0
gdc.scopus.citedcount 0
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4003-8abe-a4dfe192da5e

Files